Loading...
Liquid Embolizing Agent
Brand
- NeuroSafe Medical Co., Ltd
Model
- LAVA-12, LAVA-18, LAVA-34
Manufacturing Country
- China
Quality Certificates
CE MARKING
ISO 13485
MDR
Specification
It is indicated for the embolization of lesions in the peripheral and neurovasculature, including arteriovenous malformations(AVM) and hypervascular tumors.
Lava liquid embolizing agent is used to treat a wide range of medical conditions including brain aneurysms, arteriovenous malformations, and tumors. The product is made up of ethylene-vinyl alcohol copolymer (EVOH) dissolved in dimethyl sulfoxide (DMSO) and tantalum powder. This innovative product offers several advantages over other embolization agents. Firstly, its unique formulation and delivery system allow it to harden quickly, which means it can plug blood vessels and prevent blood flow to affected areas quickly, reducing the risk of hemorrhages and other complications. Additionally, Lava can be used in complex anatomical structures with challenging geometries and is compatible with a wide variety of delivery microcatheters. One of the key benefits of LAVA is its stability, which ensures that it does not dissolve or wash away over time. This means that it can provide long-term occlusion of blood vessels without the need for repeated treatments. Furthermore, the product is radiopaque, which makes it easy for surgeons to visualize and monitor its placement during procedures.
Features&Advantages
1. It has excellent radiopacity, which makes it easy to visualize during the embolization procedure. This is important because it allows the interventional radiologist to monitor the injection of the embolic agent and ensure that it is placed in the right location. The good radiopacity also helps in follow-up imaging, making it easier for clinicians to assess the efficacy of the embolization.
2. it has non-adhesive nature. Unlike other embolic agents, Lava does not stick to the catheter or the vessel wall, making it easier to control the injection and achieve a more uniform distribution of the embolic agent. The non-adhesive nature of Lava also reduces the risk of non-target embolization, which is a serious complication that can occur with some other embolic agents.
3. It is formulated to be injected in a slow, controlled manner, which allows it to spread evenly and fill even the most complex vascular structures. This makes it especially useful in the treatment of cerebral arteriovenous malformations, which often have a complex, tangled network of blood vessels.
4. Lava has a comprehensive models to meet different need.
Similar Products
You might also be interested in these products
